Vestische Caritas-Kliniken GmbH
- Address
- Rottstrasse 11, 45711 Datteln, Germany
Vestische Caritas-Kliniken GmbH - Neonatal Care & Ophthalmology Research
Vestische Caritas-Kliniken GmbH is a clinical research center with specialized expertise in neonatal medicine and the prevention of complications in extremely preterm infants. The center focuses on innovative therapeutic approaches to reduce vision-threatening conditions in vulnerable newborn populations.
- Retinopathy of prematurity prevention and treatment strategies
- Pharmacological interventions in extremely preterm infants
- Safety and efficacy evaluation of oral propranolol in neonatal populations
The research team investigates novel applications of established medications to address serious complications of prematurity. Their work emphasizes threshold retinopathy of prematurity, a critical stage of disease that can lead to permanent vision loss, with particular attention to safety profiles in extremely preterm infants who require specialized monitoring and care protocols.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vestische Caritas-Kliniken GmbH
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Oral Propranolol Hydrochloride for the Prevention of Threshold Retinopathy of Prematurity in Extremely Preterm Infants | Universitaetsklinikum Tuebingen AöR, Universität Zürich - Klinik für Neonatologie | Phase II | Recruiting | Jul 2024 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Propranolol Hydrochloride | 1 | Unknown | 2024-07-24 | 2024-07-24 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.